SPPI Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Spectrum Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Spectrum Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k-$50k$0$50k$100kTotal Insider BuyingTotal Insider Selling

Spectrum Pharmaceuticals Share Price & Price History

Current Price: $1.03
Price Change: +0.30 (1.20%)
As of 08/1/2023 01:00 AM ET

This chart shows the closing price history over time for SPPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Spectrum Pharmaceuticals (NASDAQ:SPPI)

21.67% of Spectrum Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SPPI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Spectrum Pharmaceuticals logo
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and license agreement with Therapyx, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Boston, Massachusetts.
Read More on Spectrum Pharmaceuticals

Today's Range

Now: $1.03
Low: $1.03
High: $1.03

50 Day Range

MA: $1.01
Low: $0.94
High: $1.03

52 Week Range

Now: $1.03
Low: $0.32
High: $1.57

Volume

N/A

Average Volume

1,927,028 shs

Market Capitalization

$211.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Who are the company insiders with the largest holdings of Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals' top insider shareholders include:
  1. Nora Brennan (CFO)
Learn More about top insider investors at Spectrum Pharmaceuticals.